• Self-Care for Oncology Patients
  • FDA Approves Revised Indication for Diabetic Macular Edema Treatment
  • Psoriasis and Psoriatic Arthritis Patient Care: What Pharmacists Should Know
  • OTC Product News (September 2014)
  • MTM Services Underused in Part D Drug Plans

Breaking News

Celebrate Pharmacy During American Pharmacists Month
In celebration of American Pharmacists Month, pharmacists are encouraged to spread the word about their work throughout the month of October.
Researchers are relying on genetics to develop new approaches for combating drug-resistant bacteria.
As the Ebola outbreak worsens, interest in therapies using recovered victims’ blood grows.
A multidisciplinary group of medical and nutrition experts hopes to shed light on misconceptions about vitamin and mineral supplementation.
Pharmacist-led drug use evaluation programs improve osteoporosis management in general practice.
The FDA has approved the intravitreal implant, Iluvien 0.19 mg, as the first long-term treatment for diabetic macular edema.
Pharmacists who participate in community-based diabetes care teams play a pivotal role in reducing A1C levels among patients with poorly controlled diabetes.

From the Issue

Previous TabNext Tab
Strategic Alliance Partners
Latest Issues